Stryker completes acquisition of Amplitude Vascular Systems
The deal adds next-generation intravascular lithotripsy technology to Stryker's peripheral vascular portfolio. Announced from Portage, Mich.
See the latest news and media coverage for Stryker. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical technology company
stryker.comLast updated
In short: Stryker launched a new handheld robotic system, completed a major vascular acquisition, and managed recovery from a March cyberattack.
The deal adds next-generation intravascular lithotripsy technology to Stryker's peripheral vascular portfolio. Announced from Portage, Mich.
Results reflect operational challenges but strong fundamentals and healthy demand. The company remains confident in financial commitments.
Net sales rose 2.6% to $6.0B. Organic growth was 2.4%. Adjusted EPS fell 8.5% to $2.60. Maintains full-year guidance.
The deal adds next-generation IVL technology to strengthen Stryker’s peripheral vascular portfolio for treating calcified arterial disease.
Despite beating Q2 estimates with 9% organic growth, Stryker's stock fell 9% as investors questioned cyber recovery and supply chain issues.
Q2 2026 earnings call highlights: 9% organic growth, EPS $3.69, guidance update, cyber recovery & supply risks.
Stryker remains a top-tier competitor in a number of attractive medical markets, including orthopedic implants, surgical instruments, endoscopy, and neurovascular devices. It enjoys a long...
Learn more Stryker has reported Q2 revenues of $6.6bn, denoting a 9.4% rise year-over-year (YoY), with the company's CEO lauding its "significant progress" in recovering...
Track Stryker and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Stryker and other trending companies.